Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects
Advanced Science · 2023-06 · 10 (16)
DOI: 10.1002/advs.202207439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.04.2023. Verfasst von Hai-Jun Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. Hauptthemen laut MEDLINE: Nuclear Proteins, Nanoparticles. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Harvard Medical School/Brigham and Women's Hospital Department of Anesthesiology-Basic Scientist, Nanotechnology Foundation, Gillian Reny Stepping Strong Center for Trauma Innovation Breakthrough Innovator.
Abstract (Originalsprache)
PROteolysis TArgeting Chimeras (PROTACs) are an emerging class of promising therapeutic modalities that selectively degrade intracellular proteins of interest by hijacking the ubiquitin‐proteasome system. However, the lack of techniques to efficiently transport these degraders to targeted cells and consequently the potential toxicity of PROTACs limit their clinical applications. Here, a strategy of nanoengineered PROTACs, that is, Nano‐PROTACs, is reported, which improves the bioavailability of PROTACs and maximizes their capacity to therapeutically degrade intracellular oncogenic proteins for tumor therapy. The Nano‐PROTACs are developed by encapsulating PROTACs in glutathione (GSH)‐responsive poly(disulfide amide) polymeric (PDSA) nanoparticles and show that ARV@PDSA Nano‐PROTAC, nanoengineered BRD4 degrader ARV‐771, improves BRD4 protein degradation and decreases the downstream oncogene c‐Myc expression. Benefiting from the GSH‐scavenging ability to amply the c‐Myc‐related ferroptosis and cell cycle arrest, this ARV@PDSA Nano‐PROTACs strategy shows superior anti‐tumor efficacy with a low dose administration and good biocompatibility in vivo. The findings reveal the potential of the Nano‐PROTACs strategy to treat a broad range of diseases by dismantling associated pathogenic proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
- Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, 171 77, Sweden.
ORCID-Profile: Wei Tao
Förderung
- Harvard Medical School/Brigham and Women's Hospital Department of Anesthesiology-Basic Scientist
- Nanotechnology Foundation
- Gillian Reny Stepping Strong Center for Trauma Innovation Breakthrough Innovator
- Center for Nanomedicine Research Fund
- Farokhzad Family Distinguished Chair Foundation
- Khoury Innovation
- American Heart Association
- U.S. METAvivor Early Career Investigator Award
Zitieren
APA
Liu, H. J., Chen, W., Wu, G., Zhou, J., Liu, C., Tang, Z., Huang, X., Gao, J., Xiao, Y., Kong, N., Joshi, N., Cao, Y., Abdi, R., & Tao, W. (2023). Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects. Advanced Science, 10(16). https://doi.org/10.1002/advs.202207439
Vancouver
Liu HJ, Chen W, Wu G, Zhou J, Liu C, Tang Z, et al. Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects. Advanced Science. 2023;10(16). doi:10.1002/advs.202207439
BibTeX
@article{Liu2023,
author = {Liu, Hai-Jun and Chen, Wei and Wu, Gongwei and Zhou, Jun and Liu, Chuang and Tang, Zhongmin and Huang, Xiangang and Gao, Jingjing and Xiao, Yufen and Kong, Na and Joshi, Nitin and Cao, Yihai and Abdi, Reza and Tao, Wei},
title = {Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {16},
doi = {10.1002/advs.202207439}
}
EUVIMED